View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

FDA tightens grip on Indian drug makers

The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

Chinese pharma probe spreads to two Danish drug makers

Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

European biotechs back on venture capital radar

Venture capital firms are once again warming to European biotechnology players, which attracted a significant portion of the venture capital invested globally in this sector during the second quarter.
Read More

Generic drug patent settlements cut costs for health systems, study finds

The U.S. health system saved a total of $25.5 billion between 2005 and 2012 thanks to generic drugs being launched on the market before patent expirations as a result of patent settlements.
Read More

U.S. pharmaceutical companies granted easier access to EU market

The United States is now considered a "listed country" by the European Commission, which means that U.S. companies don’t need an FDA export certificate before shipping certain pharmaceutical products to the European Union.
Read More

AstraZeneca to build new HQ, research center in Cambridge, UK

AstraZeneca is investing about £330 million ($515.6 million) in its new building, which will host a global R&D center.
Read More

Bill passed to fight counterfeit drugs

The United States has passed a bill intended to set up a national system for tracking pharmaceutical products through the supply chain to prevent counterfeit medicines from accessing the market.
Read More

FDA warns of counterfeit botox

The U.S. FDA has warned in recent days that fraudulent versions of Allergan's drug Botox are being distributed here in the U.S. The agency called for healthcare practitioners and the general public to exercise caution when dealing with the drug.
Read More

Bayer to acquire birth control company for $1.1 billion

Conceptus' flagship product is the Essure® procedure, a non-surgical permanent birth control method sold in the United States and other countries.
Read More

Compounding pharmacy issues recall over sterility doubts

Florida-based Balanced Solutions Compounding Pharmacy has issued a voluntary recall of all lots of its sterile non-expired drug products sold nationwide following concerns that their sterility may be compromised.
Read More